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Follicular T helper (Tfh) cells provide critical help to B
cells for germinal center (GC) formation. Mutations
affecting SLAM-associated protein (SAP) prevent
GC formation because of defective T cell-B cell inter-
actions, yet effects on Tfh cell differentiation remain
unclear. We describe the in vitro differentiation of
functionally competent ‘‘Tfh-like’’ cells that ex-
pressed interleukin-21, Tfh cell markers, and Bcl6
and rescued GC formation in SAP-deficient hosts
better than other T helper (Th) cells. SAP-deficient
Tfh-like cells appeared virtually indistinguishable
from wild-type, yet failed to support GCs in vivo.
Interestingly, both Tfh-like and in vivo-derived Tfh
cells could produce effector cytokines in response
to polarizing conditions. Moreover, Th1, Th2, and
Th17 cells could be reprogrammed to obtain Tfh
cell characteristics. ChIP-Seq analyses revealed
positive epigenetic markings on Tbx21, Gata3, and
Rorc in Tfh-like and ex vivo Tfh cells and on Bcl6 in
non-Tfh cells, supporting the concept of plasticity
between Tfh and other Th cell populations.
INTRODUCTION
Follicular T helper (Tfh) cells are key regulators of germinal center
(GC) formation and T cell-dependent long-term humoral immu-
nity (Crotty, 2011). First defined as CD4+ T cells located in human
tonsillar GCs, Tfh cells in mice express CXCR5, ICOS, PD-1, and
BTLA, molecules important for migration to B cell follicles and
providing signals for initiation and maintenance of B cell GC
responses (King et al., 2008). Tfh cells produce high amounts
of the cytokine IL-21, a potent activator of GC B cell differentia-
tion, immunoglobulin isotype switching, and plasma cell genera-
tion (Linterman et al., 2010; Spolski and Leonard, 2010; Zotos
et al., 2010). Although it remains unclear whether Tfh cells are
a distinct lineage, Tfh cells exhibit unique patterns of RNA and
microRNA expression (Yu et al., 2009). Recent data have identi-
fied the transcription factor Bcl6 as a master regulator of Tfh cell
generation (Johnston et al., 2009; Nurieva et al., 2009; Yu et al.,622 Immunity 35, 622–632, October 28, 2011 ª2011 Elsevier Inc.2009), further supporting that this is a distinct subpopulation of
cells.
However, the concept of T helper (Th) cell lineages has been
recently challenged by data supporting substantial plasticity
between different effector cell populations (O’Shea and Paul,
2010; Wei et al., 2009; Zhou et al., 2009). Tfh cells within the
GC can express cytokines characteristic of other Th cells,
most notably IL-4 (characteristic of Th2 cells) (Fazilleau et al.,
2009; King and Mohrs, 2009; Reinhardt et al., 2009; Smith
et al., 2000; Yusuf et al., 2010; Zaretsky et al., 2009), but also
IL-17 (Th17 cells) (Bauquet et al., 2009) and IFN-g (Th1 cells)
(Johnston et al., 2009; Reinhardt et al., 2009; Smith et al.,
2000). Furthermore, other data indicate that FoxP3+CD4+ regu-
latory T (Treg) cells can differentiate into functional Tfh cells
(Chung et al., 2011; Linterman et al., 2011; Tsuji et al., 2009).
These data support the concept of reprogramming plasticity
between polarized Th cell populations. Thus, whether Tfh cells
are a separate cell population or a stage in effector T cell differ-
entiation remains unclear. Because cytokines such as IL-4
and IFN-g induce B cell immunoglobulin class-switching, the
relationship between Tfh and other CD4+ effector cells is of
increasing importance for understanding regulation of mature
antibody responses.
Recent studies have suggested that contact between T and B
cells and/or sustained antigen stimulation are critical for Tfh cell
generation (Deenick et al., 2010; Fahey et al., 2011; Fazilleau
et al., 2009; Haynes et al., 2007; Johnston et al., 2009; Zaretsky
et al., 2009). In this regard, mice deficient in the SLAM-associ-
ated protein (SAP) are of interest. These mice have impaired
T cell help for GC generation, associated with selective defects
in T cell-B cell adhesion (Cannons et al., 2006, 2010; Crotty
et al., 2003; Czar et al., 2001; Hron et al., 2004; Qi et al., 2008).
However, the role of SAP in Tfh cell differentiation remains
unclear. SAP-deficient CD4+ cells are activated normally by
dendritic cells (DCs) and initially express Tfh cell markers
(Cannons et al., 2010; Kamperschroer et al., 2008; Qi et al.,
2008). However, other data suggest that SAP deficiency reduces
or eliminates Tfh cells in GCs (Cannons et al., 2010; Linterman
et al., 2009; Yusuf et al., 2010). Such data suggest that SAP
affects a late stage required to generate functional Tfh cells
and that Tfh cell differentiation is a multistep process.
Given the critical role of Tfh cells in GC formation and long-
term humoral immunity, understanding requirements for their
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entiation of Th1, Th2, Th17, and Treg cells, in vitro culture studies
have been invaluable for delineating requirements for cytokines,
signaling proteins, and transcription factors, as well as evalua-
tion of gene expression and epigenetic modifications (Zhu
et al., 2010). However, knowledge of Tfh cells is limited, in part,
because of the lack of robust in vitro models. Recent studies
have described in vitro generation of cells expressing IL-21
and other Tfh cell characteristics, but these cells were either
primarily evaluated for gene expression or not evaluated for
in vivo function (Nurieva et al., 2008; Suto et al., 2008).
We describe the in vitro differentiation of functionally compe-
tent IL-21-producing cells with Tfh-like cell properties. Impor-
tantly, transfer of low numbers of these cells induced GC
formation in SAP-deficient hosts more effectively than other
in vitro-differentiated Th cells, suggesting that they represent
bona fide Tfh cell precursors. We have chosen the name ‘‘Tfh-
like’’ cells for these in vitro-differentiated IL-21-producing cells
because they exhibit Tfh cell characteristics but do not reside
within B cell follicles. SAP-deficient Tfh-like cells were virtually
indistinguishable from WT, yet nonetheless failed to effectively
contribute to Tfh cells and rescue GC formation in vivo. Evalua-
tion of cytokine production as well as epigenetic chromatin
modifications of genes encoding Th cell-specific transcription
factors from either in vitro-generated Tfh-like cells or Tfh cells
isolated directly ex vivo provided evidence for plasticity between
Tfh-like and other Th cell populations, including Th1, Th2, and
Th17 cells. Our results provide insight into the requirements for
differentiation and plasticity of Tfh cells, which are critical for
the generation of effective long-term humoral immunity.
RESULTS
In Vitro-Differentiated IL-21-Producing Cells Have
Characteristics of Tfh Cells
To evaluate differentiation of a Tfh-like cell population in vitro, we
stimulated sorted naive CD4+ T cells from OT-II mice in the pres-
ence of mitomycin-treated T cell-depleted splenocytes as
antigen-presenting cells (APCs) and neutralizing antibodies
against IL-4, IL-12, IFN-g, and TGF-b, along with IL-6 and
IL-21, cytokines important for Tfh cell differentiation in vivo and
IL-21 production in vitro (Eto et al., 2011; Nurieva et al., 2008;
Suto et al., 2008; Vogelzang et al., 2008). Differentiation under
these conditions resulted in a large population of IL-21-
producing cells (Figures 1A and 1B; see Figure S1A available
online), detected by intracellular staining with an IL-21R-Fc-
chimera (IL-21R-Fc) (Suto et al., 2008). T cells deficient in
STAT3, the major STAT activated by IL-6 and IL-21 (Wei et al.,
2007), failed to produce IL-21, demonstrating a requirement for
STAT3-activating cytokines, as well as the specificity of the
IL-21R-Fc reagent (Figure S1B).
In vitro differentiation of Th17 cells, another Th cell subset with
high IL-21 expression, is enhanced by IMDM media, which is
enriched with aryl hydrocarbons and amino acid precursors
(Veldhoen et al., 2009). Similarly, we found increased percent-
ages of IL-21+ Tfh-like cells in IMDM media, compared to
RPMI media (Figure 1A).
Further examination of in vitro Tfh-like cells revealed only low
percentages of cells producing IFN-g, IL-4, or IL-17A (Figure 1B).Likewise, Tfh-like cells had abundant Il21 and low Ifng, Il4, and
Il17a transcripts (Figure S1D). Interestingly, Tfh-like cells ex-
pressed more IL-2 than other Th cells (Figure 1B and data not
shown), consistent with high IL-2 production in CXCR5hi human
tonsillar T cells (Yu et al., 2009).
Tfh cells are distinguished by elevated expression of CXCR5,
a chemokine receptor responsible for migration to B cell follicles
(Schaerli et al., 2000), and PD-1, an inhibitory signaling molecule
that regulates GC B cell survival (Good-Jacobson et al., 2010).
These markers are induced upon T cell activation; however,
highest expression is sustained on Tfh cells (Haynes et al.,
2007). Although a distinct subpopulation of CXCR5+PD-1+ cells
was seen in all in vitro-differentiated cell populations, Tfh-like
cells had the greatest percentage of CXCR5+PD-1+ cells (Figures
1C and S1C) with the highest CXCR5 intensity (Figure 1C,
inserts) and the greatest expression of Blr1, which encodes
CXCR5 (Figure 1D). Tfh cells also express ICOS, BTLA, and
the SLAM family member CD84 (Cannons et al., 2010; Chtanova
et al., 2004; Nurieva et al., 2008). Whereas ICOS was induced on
both Tfh-like and, as previously reported, Th2 cells (McAdam
et al., 2000), BTLA and CD84 were distinctly elevated on Tfh-
like cells (Figure 1E). Importantly, expression of CXCR5, PD-1,
ICOS, BTLA, and CD84 was comparable to that on CXCR5+
PD-1+ Tfh cells directly isolated ex vivo (Figure S1E).
We further found that Tfh-like cells exhibited the greatest
expression of Bcl6, which increased over 5 days in culture (Fig-
ure 1F). This expression was not secondary to B cell contamina-
tion, because similar results were seen with CD4+CD19 sorted
cells. In contrast, expression of Tbx21, Gata3, and Rorc in Tfh-
like cells was very low compared to Th1, Th2, and Th17 cells,
respectively (Figure 1G). Thus, Tfh-like cells share phenotypic
characteristics of Tfh cells, which differ from Th1, Th2, and
Th17 cell subsets.
In Vitro-Differentiated SAP-Deficient Tfh-like Cells
Resemble WT Tfh-like Cells
T cells deficient in SAP are unable to provide contact-dependent
signals necessary for GC formation, despite expression of Tfh
cell markers required for follicular localization and B cell help
(Qi et al., 2008). However, SAP-deficient (Sh2d1a/) mice
have also been reported to have lower numbers of Tfh cells
and reduced IL-21 production from splenocytes (Cannons
et al., 2010; Linterman et al., 2009). Under Tfh-like cell culture
conditions, percentages of IL-21+ and CXCR5+PD-1+ popula-
tions of Sh2d1a/ cells were similar to WT (Figures 2A and
2B), as was expression of ICOS, BTLA, and CD84 (Figure 2C).
Moreover, global gene expression in Sh2d1a/ Tfh-like cells
closely resembled that of WT Tfh-like cells (WT versus
Sh2d1a/, R2 = 0.93051) (Figure 2D). Indeed, the gene most
differentially expressed (193) was Sh2d1a; only two other genes
(Itsn and Rab4a)were identified with greater than a 2-fold reduc-
tion in expression, in comparison to WT Tfh-like cells. Thus,
in vitro-differentiated Sh2d1a/ Tfh-like cells were virtually
indistinguishable from WT.
In Vitro-Differentiated WT, but Not Sh2d1a–/–, Tfh-like
Cells Induce GC Formation
To evaluate the ability of in vitro-differentiated Tfh-like cells
to initiate and maintain GC responses in vivo, we adoptivelyImmunity 35, 622–632, October 28, 2011 ª2011 Elsevier Inc. 623
Figure 1. In Vitro-Generated Tfh-like Cells Are Distinct from Other Th Cells
(A and B) Sorted naive CD4+ T cells from WT mice were assessed for IL-21, IFN-g, IL-4, IL-17, and IL-2 cytokine production after 3.5 days in Tfh-like or Th0 cell
culture conditions in RPMI (A) or IMDM media (A and B).
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Figure 2. In Vitro-Differentiated Sh2d1a–/– Tfh-like Cells Resemble
WT Tfh-like Cells
(A–C) WT and Sh2d1a/ sorted naive CD4+ T cells cultured under Tfh-like cell
conditions and evaluated for IL-21 and IL-17 production (A, top and B), surface
CXCR5+PD-1+ (A, bottom), and ICOS, BTLA, and CD84 (C).
(D) Microarray pairwise comparison of gene expression in WT and Sh2d1a/
Tfh-like cells (from independent biological triplicates, with two to three mice
per experiment).
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tiated cells into Sh2d1a/ recipients, which lack GCs. After
immunization with NP-OVA, a specific T cell-dependent antigen,
a subset of B cells downregulate IgD and express GC markers,
including Fas and GL7. In the absence of transferred cells, very
low percentages of B220+IgDloGL7hiFashi B cells were detected
in the draining lymph nodes of Sh2d1a/ hosts 6 days postim-
munization (Figure 3A, left). However, transfer of WT Tfh-like
cells resulted in robust generation of GCs in Sh2d1a/ recipi-
ents, equivalent to that seen in immunized WT mice (Figure 3A,
top right, and 3B). Notably, WT Tfh-like cells improved GC
formation significantly better than WT naive, Th0, Th1, Th2, or
Th17 cells (p < 0.005; Figures 3A, 3B, and S2A). Consistent
with the role of CXCR5 in homing to B cell zones, sorted
CXCR5+ Tfh-like cells were more efficient than CXCR5 cells,(C) In vitro-differentiated Th1, Th2, Th17, and Tfh-like cells were gated on CD4+CD
B cell doublets were excluded by CD19 staining. Mean ± SD of percent CXCR5+
cells and respective Th cells (gray). Summaries of IL-21+ and CXCR5+PD-1+ cell
(D) Relative expression ofBlr1, compared inWT naive and in vitro-differentiated Th
18S rRNA and normalized to naive CD4+ T cells.
(E) Surface expression of ICOS, BTLA, and CD84. Flow cytometry is representativ
(F and G) Relative expression of genes encoding Th cell-specific transcription
populations. Expression was calculated in reference to 18S rRNA and normalized
Data in (D), (F), and (G) represent the mean ± SEM of at least three experiments, wyet both could provide help for GC formation (data not shown).
Similarly, WT transferred Tfh-like cells contributed to the CD4+
CD44hiCXCR5+PD-1+ Tfh cell population in Sh2d1a/ hosts
(Figure 3C). Thus, in vitro-differentiated Tfh-like cells contribute
to functional Tfh cells to support GC formation in vivo and do
so more effectively than other Th cell populations, including
Th0, Th1, Th2, and Th17 cells.
In contrast, Sh2d1a/ Tfh-like cells failed to rescue GC
responses (Figures 3A, bottom, and 3B), despite having an
almost identical phenotype to WT cells in vitro. Histological
examination confirmed GC formation in Sh2d1a/ recipients
that received WT, but not Sh2d1a/ Tfh-like cells. Transferred
GFP+ WT Tfh-like cells were found within the GC structure, as
well as in the B cell follicles and in the T cell zone along the follicle
borders (Figure 3E). In contrast, although GFP+Sh2d1a/ Tfh-
like cells were found in B cell follicles, they failed to induce
GCs. Evaluation by flow cytometry 4 and 8 days after immuniza-
tion revealed that Sh2d1a/ Tfh-like cells mainly contributed to
the CXCR5+PD-1+ population at early times postimmunization
(Figure S2B and data not shown). Moreover, by day 6 after
immunization, a greater percentage ofWT Tfh-like GFP+CXCR5+
PD-1+ cells were found in the draining lymph nodes than trans-
ferred Sh2d1a/ cells (Figures 3C and 3D). Thus, Sh2d1a/
Tfh-like cells are either not retained or not expanded within the
lymph node environment. Interestingly, other WT Th cell popula-
tions could contribute to Tfh cells when transferred in vivo,
although with delayed efficiency, suggesting that these cells
acquired Tfh-like cell properties to promote GC formation (Fig-
ure S2B and data not shown).
Sh2d1a/mice also have reduced antigen-specific immuno-
globulins after T cell-dependent immunization. Transfer of WT
Tfh-like cells into Sh2d1a/ recipients prior to immunization
greatly enhanced NP-specific antibody titers, in some cases
even above those in WT immunized mice (Figure 3F). Transfer
of WT Th1 and Th2 cells also improved NP-specific total IgG,
IgG1, and IgG2b antibody titers, albeit less well than Tfh-like
cells and with different efficiency, depending on the isotype (Fig-
ure S2C; Cannons et al., 2006). In contrast, Sh2d1a/ Tfh-like
cells failed to rescue NP-specific IgG titers. Thus, although
Sh2d1a/ and WT Tfh-like cells are phenotypically indistin-
guishable, only WT Tfh-like cells functioned as Tfh cells in vivo
to rescue GC responses in Sh2d1a/ mice and did so better
than other CD4+ effector Th cells.Tfh-like Cells Can Acquire Properties Characteristic
of Other Effector Th Cells
Several recent reports have shown overlapping cytokine
patterns between Tfh cells and other Th cell lineages in response
to specific parasitic infections, suggesting plasticity in cytokine19CD44+ cells and evaluated for surface CXCR5 and PD-1. B cells and T cell-
PD-1+ cells are shown below each plot. Inserts: CXCR5 expression on Tfh-like
s are shown in Figures S1A and S1C.
0, Th1, Th2, Th17, and Tfh-like cells. Expression was calculated in reference to
e of five or more independent experiments with two to threemice per genotype.
factors Bcl6 (F) and Tbx21, Gata3, and Rorc (G) in Tfh-like and other Th cell
to Th0 cells (Bcl6), naive CD4+ T cells (Tbx21 and Gata3), or Th2 cells (Rorc).
ith two to three mice per experiment. **p < 0.005; *p < 0.05; nd, not detectable.
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Figure 3. WT Tfh-like Cells Promote GC Response in Sh2d1a–/– Mice
GC B cells (B220+IgDloGL7hiFashi) in draining lymph nodes 6 days postimmunization with NP-OVA in Alum.
(A) Left: WT or Sh2d1a/mice without cell transfers. Middle and right: transfer of WT or Sh2d1a/ in vitro-generated Th2 or Tfh-like cells into Sh2d1a/ hosts
1 day prior to immunization.
(B) Summary of percent GCB cells inSh2d1a/mice after cell transfer and immunization. ImmunizedWTmice had an average of 14.35 ± 0.65 SEMpercent GCB
cells. Transferred cells: WT, filled circles; Sh2d1a/, open circles; no cells transferred (nt), open triangles. p < 0.005 for WT Tfh-like cell transfers compared to all
other cell transfers.
(C) Tfh cells (CXCR5+PD-1+) in Sh2d1a/ mice after transfer of Tfh-like cells and immunization. Left: total Tfh cells (gated on CD4+CD44hi). Right: transferred
donor cells (gated on CD4+CD44hiGFP+).
Data in (A) and (C) are representative of three or more independent experiments 6 days postimmunization.
(D) Summary of percent GFP+ cells, 6 days postimmunization in draining LNs of Sh2d1a/ mice that received WT or Sh2d1a/ Tfh-like cells. Data points
represent one mouse, from three or more independent experiments. **p < 0.005.
(E) Immunofluorescence of draining lymph node sections. Top: GFP+ OT-II cells (GFP+, green); GC (PNA, red); follicle (IgD, blue), 6 days after immunization.
Middle: IgD and GFP+ cells only. Bottom: GFP staining alone for better visualization.
(F) NP-specific antibody titers (total IgG, IgG1, IgG2b) measured by ELISA.
Data depict the mean ± SEM from three independent experiments. Related to Figure S2.
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Figure 4. Epigenetic State and Cytokine Plasticity of Tfh-like Cells
(A and B) Evaluation of cytokine production (A) and CXCR5+PD-1+ expression
(B) after two rounds of Tfh-like cell polarization. Percentage of CXCR5+PD-1+
cells after one round of Tfh-like cell polarization is listed below (B). Data are
representative of three or more independent experiments.
(C–F) Genome browser view of ChIP-Seq profile maps.
(C and D) Distributions of H3K4me3 (blue) and H3K27me3 (red) on genes
encoding Th cell-determining transcription factors, Tbx21 (chr11:96,942,182-
96,993,793), Gata3 (chr2:9,764,070-9,826,790), and Rorc (chr3:94,143,165-
94,220,573) shown for (C) double-polarized in vitro-generated Th cells and
Tfh-like cells and for (D) sorted CD4+CD19–CD44hiCXCR5+PD-1+ in vitro-
differentiated Tfh-like cells and Tfh cells isolated ex vivo from SRBC-immu-
nized mice. Biological triplicates of Th cell cultures with comparison to data
from Wei et al. (2009) are shown in Figure S3A.
(E and F) Distributions of H3K4me3 (blue) and H3K27me3 (red) on Th cell-
specific cytokine genes Ifng (chr10:117,864,373-117,896,679), Il4 (chr11:53,
418,049-53,445,596), and Il17a (chr1:20,710,659-20,734,904) shown for (E)
double-polarized in vitro-generated Th cells and Tfh-like cells and (F) sorted
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that plasticity between Th cell populations is associated with
the presence of active epigenetic modifications of the genes
encoding Th cell lineage-restricted transcription factors, even
in lineages where these factors are not expressed (Wei et al.,
2009). Thus, although the presence of positive chromatin
modifications, such as lysine 4 trimethylation of histone H3
(H3K4me3), and negative modifications, such as H3K27me3,
largely conform to the patterns of cytokine expression of distinct
Th cells, the genes encoding the regulatory transcription factors
exhibit positive (H3K4me3) chromatin modifications in multiple
effector Th cell populations, suggesting that they are poised
for expression (Wei et al., 2009). To evaluate epigenetic modifi-
cations of the genes encoding the master regulatory transcrip-
tion factors in Tfh-like cells, we first subjected CD4+ T cells to
two rounds of polarization in Tfh-like cell conditions. Although
sequential polarizations did not increase the percentage of
IL-21+ cells (Figure 4A and data not shown), the majority of cells
became CXCR5+PD-1+ (Figure 4B).
We then performed high-density sequence analyses of
H3K4me3 and H3K27me3 chromatin immunoprecipitations
(ChIP-Seq) on double-polarized Tfh-like cells. Although the
vast majority of Tfh-like cells produced only IL-21, H3K4me3
histone modifications were observed on the genes encoding
transcription factors considered master regulators of other
effector CD4+ T cell populations, including Tbx21 (Th1), Gata3
(Th2), andRorc (Th17) (Figure 4C, see Figure S3A for comparison
of independent biological triplicate samples). These findings are
consistent with the ability of Tfh cells to express other effector
cytokines depending on the in vivo challenge (King and Mohrs,
2009; Poholek et al., 2010; Reinhardt et al., 2009; Yusuf et al.,
2010; Zaretsky et al., 2009).
One concern with such studies is that these findings result
from heterogeneous cell populations. To start to address these
issues, we sorted CD4+CD19CD44hiCXCR5+PD-1+ cells from
in vitro Tfh-like cell cultures, as well as frommice 6 days postim-
munization with SRBC. At this time point, GCs are well formed
in WT mice. In both CXCR5+PD-1+ sorted Tfh-like and Tfh cells
isolated directly ex vivo, positive marks were detected on the
effector Th cell-determining transcription factor loci Tbx21,
Gata3, and Rorc (with the exception of weaker H3K4me3 marks
on Rorc in ex vivo Tfh cells) (Figure 4D), suggesting that these
genes were poised for activation.
Consistent with their low expression by in vitro Tfh-like cells,
the genes encoding effector cytokines characteristic of other
CD4+ effector T cells (Ifng, Il4, and Il17a) showed either low or
no positive marks in the total Tfh-like cell population in compar-
ison to Th1, Th2, and Th17 cells, respectively (Figure 4E). EvenCD4+CD19-CD44hiCXCR5+PD-1+ in vitro Tfh-like cells and ex vivo Tfh cells.
Gene structure is from the UCSC Genome Browser. Where no signals were
detected, corresponding columns are blank. Vertical scales are noted.
(G) Cytokine production examined after repolarization of Tfh-like cells under
Th1, Th17, and Th2 cell conditions.
(H) Cytokine production of sorted Tfh cells after isolation ex vivo and rested
1 day in the presence of IL-2 (top) and after repolarization under Th1, Th2, and
Th17 cell conditions (bottom).
Data in (G) and (H) are representative of three or more independent experi-
ments.
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Figure 5. Histone H3K4me3 and H3K27me3 Modifications of Bcl6
and Prdm1
H3K4me3 (blue) and H3K27me3 (red) modifications on (A, B) Bcl6
(chr16:23,941,577-24,012,259) and (C, D) Prdm1 (chr10:44,133,792-44,279,
402) loci in (A, C) naive CD4+ T cells, and double-polarized Th1, Th2, Th17, Tfh-
like, and (B, D) CD4+CD19CD44hiCXCR5+PD-1+ sorted Tfh-like cells and Tfh
cells isolated ex vivo from SRBC-immunizedmice. Naive CD4+ T cell sample is
from Wei et al. (2009). Biological triplicates for Th cell cultures are shown in
Figure S4.
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tected on Ifng, Il4, and Il17 in the CXCR5+PD-1+ population
from in vitro-differentiated Tfh-like cells and on Ifng and Il4 in
Tfh cells isolated directly ex vivo (Figure 4F), suggesting that
both populations had the potential for expression of these
effector cytokines. Positive marks were detected in Tfh-like
and Tfh cells on the Il21 and Il2 loci, consistent with their high
expression (Figures S3B).
To determine whether these chromatin modifications corre-
lated with potential for cytokine production, we repolarized
predifferentiated Tfh-like cells under Th1, Th2, or Th17 cell
conditions. Cytokine analysis revealed that these repolarized
Tfh-like cells acquired the ability to produce IFN-g, IL-4, or
IL-17, respectively (Figure 4G), while still producing IL-21, sug-
gesting that the acquisition of effector cytokine production could
occur from the IL-21-producing population. Increased expres-
sion of the genes encoding T-bet, GATA3, and RORgt were
also observed under appropriate conditions of repolarization
(Figure S3C). To confirm these findings in Tfh cells isolated
ex vivo, we sorted CD4+CD19CD44hiCXCR5+PD-1+ Tfh cells628 Immunity 35, 622–632, October 28, 2011 ª2011 Elsevier Inc.frommice immunized with SRBCs. Cells were cultured and cyto-
kine production examined either prior to or after restimulation
under Th1, Th2, and Th17 cell polarizing conditions. The primary
cytokine detected in ex vivo Tfh cells was IL-21; however, these
cells could produce Th1, Th2, and Th17 cytokines upon repolar-
ization (Figure 4H). Although we cannot rule out the effects of
heterogeneity even in the sorted cell populations, these results
suggest that both in vitro- and early stage ex vivo-derived Tfh-
like cells retain the ability to express cytokines of other effector
T cells.
Bcl6 Exhibits H3K4me3 Modifications in Multiple
Th Cell Populations
To further evaluate the potential plasticity among effector Th
cells, we compared epigenetic modifications of Bcl6 in naive
CD4+ cells to Tfh-like and other Th cell populations that had
undergone two rounds of polarization. As expected, predomi-
nantly positive marks (H3K4me3) were detected in Tfh-like and
ex vivo Tfh cells at the Bcl6 locus (Figures 5A and 5B). Surpris-
ingly, Th1, Th2, and Th17 cells all displayed H3K4me3 markings
at the Bcl6 locus (Figures 5A and S4A for independent biological
triplicate samples), suggestive of the ability of these cells to
acquire characteristics of Tfh cells.
Expression of Bcl6 is antagonized by Blimp1, encoded by
Prdm1, which is highly expressed in non-Tfh CD4+ T helper cell
lineages (Crotty, 2011; Johnston et al., 2009). Both H3K4me3
and H3K27me3 modifications of Prdm1 were detected in all
T helper cell populations, including the total (Figures 5C and
S4B) and sorted CXCR5+PD-1+ Tfh-like cells, and, importantly,
the ex vivo Tfh cells from immunized mice (Figure 5D). The
presence of positive marks on Bcl6 and Prdm1 in multiple
Th cell populations supports the potential for reprogramming
between Tfh cells and other effector CD4+ T cells.
To further evaluate the relationship between Tfh-like cells and
other effector cell populations, we examined cytokine expres-
sion by Th1, Th2, and Th17 cells (Figure 6A). As previously
demonstrated, all three populations expressed Il21 transcripts
(Figure S1D; Spolski and Leonard, 2010). Surprisingly, high
percentages of these cells produced IL-21, perhaps because
of culture conditions in IMDM. Although the majority of our Th1
cells produced only IFN-g (Figure 6A), our Th2 cell cultures
contained cells that produced only IL-4, along with populations
that produced both IL-4 and IL-21 or only IL-21 (Figure 6A).
Under Th17 cell conditions, the majority of the cytokine-
producing cells produced both IL-17 and IL-21, along with pop-
ulations that expressed only IL-17 or IL-21 (Figure 6A, right). After
expansion in IL-2, cells were repolarized under Tfh-like cell
conditions and evaluated for cytokine production. Repolarized
Th1 and Th2 cells had a greater capability to produce IL-21,
in conjunction with maintaining production of their primary
effector cytokines IFN-g or IL-4 (Figure 6B). In repolarized Th17
cells, an increase of the sole IL-21-producing population was
observed. Notably, CXCR5+PD-1+ populations were enhanced
in all the Tfh-like repolarized cell subsets (Figure 6C) and
increased Bcl6 mRNA was observed in repolarized Th2 and
Th17 cells (Figure S5). These results suggest that Th1, Th2,
and Th17 cells retain the potential to express Tfh cell char-
acteristics upon restimulation in the appropriate cytokine
environment.
Figure 6. Repolarization of Th1, Th2, and Th17 Cells in Tfh-like
Conditions
(A) Cytokine production from polarized Th1, Th2, and Th17 cells.
(B and C) Cells were rested, repolarized under Tfh-like cell conditions, and
evaluated for cytokine production (B) and surface markers CXCR5 and PD-1
(C). The percentages of CXCR5+PD-1+ cells of the original polarized Th1, Th2,
and Th17 cell populations are listed in parentheses.
Data are representative of three or more independent experiments. Related to
Figure S5.
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Using defined in vitro conditions, we have examined the differen-
tiation of naive CD4+ T cells into cells with characteristics of Tfh
cells, including the ability to provide efficient help for GC forma-
tion in vivo. These in vitro-generated Tfh-like cells are notable for
their high expression of BTLA, ICOS, CD84, IL-21, and IL-2, low
expression of other effector cytokines, and the presence of
a subpopulation with increased CXCR5 and PD-1, all of which
are comparable to Tfh cells isolated ex vivo. Furthermore, in
comparison to Th0, Th1, Th2, and Th17 cell populations, these
cells exhibit greater expression of Bcl6.
With some exceptions, Tfh cells are found to reside within the
GC aswell as along the boundaries of the T cell-B cell zones, and
may require prolonged B cell or other secondary APC interac-
tions to acquire full effector cell function (Baumjohann et al.,
2011; Cannons et al., 2010; Crotty, 2011; Deenick et al., 2010;
Goenka et al., 2011; Qi et al., 2008). Although our Tfh-like cells
are generated in vitro, the ability of these cells to potently induce
GCswhen transferred in vivo strongly argues that they contributeto functional Tfh cells. For this reason, we refer to them as
‘‘Tfh-like’’ cells, but alternatively they may be considered a
‘‘pre-Tfh’’ cell because of their resemblance to Tfh cells early in
humoral responses, or a ‘‘Th21’’ cell, because of their cytokine
expression being primarily limited to IL-21. Whether these
in vitro-differentiated cells represent bona fide Tfh cells, as
opposed to a Tfh cell precursor, may require further evaluation.
However, these cells have permitted examination of questions
about early Tfh cell differentiation and epigenetic modifications,
which, importantly, wewere able to confirmwith primary Tfh cells
isolated directly ex vivo from mice. Strikingly, both ex vivo and
in vitro cells exhibit evidence for multipotential cytokine produc-
tion, accompanied by epigenetic modifications consistent with
plasticity of expression of regulatory transcription factors.
We have used this system to probe the requirements for differ-
entiation of Tfh-like cell populations. Similar to studies on IL-17a
(Veldhoen et al., 2009), we found that IMDM also enhanced
generation of IL-21-expressing cells, suggesting that IMDM
components enhance production of multiple cytokines. We
further found a requirement for STAT3 for in vitro production of
IL-21 in these culture conditions. Although the requirements for
IL-6 and IL-21 for Tfh cells and GC formation in vivo are contro-
versial (Eddahri et al., 2009; Eto et al., 2011; Nurieva et al., 2008;
Poholek et al., 2010; Vogelzang et al., 2008), blockade of IL-6 and
IL-21 prevented IL-21 production in Tfh-like cell culture condi-
tions (data not shown). Whether other cytokines or pathways
may substitute in vivo or in vitro will require further examination.
It is notable that patients expressing a dominant-negative muta-
tion of STAT3 still develop GC responses, suggesting that there
may be multiple pathways of Tfh cell differentiation, an idea that
would be consistent with the concept of Th cell plasticity.
Because prolonged interactions with B cells or other APCs
have been implicated in development of Tfh cells in vivo, we
utilized mitomycin C-treated T cell-depleted splenocytes as
APCs to preserve the antigen-presenting function of B cells
(Webb et al., 1985). Although in our hands isolated splenic
CD11c+ DCs and T cell-depleted splenocytes induced similar
amounts of IL-21 and CXCR5, T cells activated with T cell-
depleted splenocytes induced twice the percentage of GC B
cells (data not shown). Thus, although DCs can confer Tfh cell
phenotypes upon CD4+ T cells, the presence of B cells and/or
prolonged antigen stimulation may be important for Tfh cell
differentiation and function.
Supporting this idea, SAP deficiency did not intrinsically alter
the initiation of a Tfh cell differentiation program, although it pre-
vented Tfh-like cells from functioning in vivo, consistent with
defects in T cell-B cell interactions (Cannons et al., 2010; Qi
et al., 2008). These results were not due to reduced efficiency;
increasing the number of transferred cells did not improve GC
formation (data not shown). However, whether these observa-
tions result from an inability of Sh2d1a/ T cells to undergo a
late differentiation process is not clear. Indeed, although IL-21
(Spolski and Leonard, 2010), ICOS (Tafuri et al., 2001), CXCR5
(Ansel et al., 1999), and PD-1 (Agata et al., 1996) are induced
by initial T cell activation, Tfh cells may specifically maintain or
increase their expression, perhaps because of prolonged or
secondary antigen encounter (Kerfoot et al., 2011; Kitano et al.,
2011). Our findings are consistent with the concept that Tfh cell
differentiation is a multistep process that requires secondaryImmunity 35, 622–632, October 28, 2011 ª2011 Elsevier Inc. 629
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2011; Choi et al., 2011; Deenick et al., 2010; Goenka et al., 2011).
Recent studies suggest that Tfh cells exhibit features overlap-
pingwith other effector Th cell populations (Spolski and Leonard,
2010). Consistent with this idea, we found that in vitro Tfh-like
cells can be induced to produce other effector cytokines. Like-
wise, other effector CD4+ T cell populations, including Th1,
Th2, and Th17 cells, can be induced to express Tfh cell markers.
Our results provide evidence for reprogramming capacity at
least between early Tfh-like cells and other effector Th cell pop-
ulations. This reciprocal plasticity in cytokine production does
not appear to result solely from the presence of nondifferentiated
cells in the culture, because many of the Tfh-like cells produced
both IL-21 and other effector cytokines upon exposure to
secondary polarization. Notably, our findings were confirmed
with sorted CXCR5+PD-1+ Tfh cells isolated directly ex vivo,
which also could be induced to produce IFN-g, IL-4, and IL-17
after exposure to polarizing cytokines.
This potential for plasticity is reinforced by evaluation of the
chromatin landscape of the genes encoding the master regula-
tors of Th cell differentiation. Although variability was observed
in certain markings, Tfh-like cells consistently displayed active
marks on the Tbx21, Gata3, and Rorc loci, even though the
vast majority of these cells expressed IL-21 in the absence of
other cytokines. Importantly, positive chromatin modifications
on Tbx21, Gata3, and Rorc were also observed in sorted
in vitro CXCR5+PD-1+ Tfh-like cells, as well as Tfh cells sorted
directly ex vivo.
Conversely, in most non-Tfh-like cells, including naive cells,
Bcl6 and Prdm1 exhibited active chromatin marks. The universal
presence of H3K4me3 marks on Bcl6 may reflect the ability of
multiple Th cell populations (including naive cells) to initially
expressmarkers of Tfh cells upon activation. Even though recent
data demonstrate an early bifurcation of Tfh and non-Tfh cells
(Choi et al., 2011), our data suggest that these populations retain
the potential to express both Bcl6 and Blimp1 and therefore
maintain the ability to adopt Tfh or other Th cell properties in
the proper context. Indeed, Bcl6 is coexpressed with and regu-
lates other Th cell-specific transcription factors, suggesting that
it is the balance of transcription factors that determines cell
phenotype (O’Shea and Paul, 2010; Oestreich et al., 2011;
Zhou et al., 2009; Zhu et al., 2010). The presence of active chro-
matin modifications on genes encoding Th effector cell lineage-
specific transcription factors suggest that Tfh-like cells have
a global reciprocal reprogramming capacity with other effector
Th cell populations. Although we cannot rule out that these find-
ings could reflect heterogeneity in our cultured cells or even in
Tfh cells sorted from immunized mice at the early time points
used in this study (6 days postimmunization), our results suggest
that Tfh cells constitute a state of differentiation for CD4+ effector
cells that can be associated with multiple cytokine-producing
capacities.
Our findings therefore argue that CD4+ T cells can gain distinct
cytokine expression profiles of given effector Th cell populations
upon activation by DCs, yet still maintain the potential to adopt
Tfh cell characteristics. This flexibility would permit CD4+
T cells to migrate to the B cell follicle for induction of GCs,
even after expression of other cytokine-producing fates, allow-
ing them to orchestrate appropriate antibody class switching630 Immunity 35, 622–632, October 28, 2011 ª2011 Elsevier Inc.and production of specific immunoglobulin subclasses suited
for a given infection. Conversely, cells that adopt Tfh cell charac-
teristics, such as in the context of prolonged or repeated stimu-
lation, may still possess the potential to produce other effector
cytokines, thereby allowing appropriate contouring of humoral
responses. Our work, therefore, suggests flexibility in effector
T cell responses that permit CD4+ T cells to effectively coordi-
nate integrated immune responses to pathogens. Whether
such plasticity can be exploited to better induce specific anti-
body isotypes may be important for development of optimal
long-term humoral immunity in response to vaccines and other
immune challenges.
EXPERIMENTAL PROCEDURES
Mice
Sh2d1a/ mice (Czar et al., 2001) were backcrossed to C57BL6/J for 10
generations. CD4-Cre Stat3fl/fl mice were described (Wei et al., 2007).
C57BL/6, Ub-GFP expressing, and OVA323-339-specific TCR-transgenic
OT-II mice were from Jackson Laboratory. Mice were maintained and used
under specific-pathogen-free conditions in accordance of NIH institutional
guidelines for animal welfare.
Cell Isolation and T Helper Cell Differentiation
Mouse CD4+ T cells were purified from spleens and lymph nodes by negative
selection (CD4+ T cell isolation kit, Miltenyi Biotec). Naive (CD4+CD62L+
CD44loCD25) or Tfh (CD4+CD19CD44hiCXCR5+PD-1+) cells from mice
immunized with SRBC (Colorado Serum Company) (Cannons et al., 2006)
were sorted on a FACSAria (>95% purity). Differentiation of Th cells was modi-
fied from previous protocols (Gomez-Rodriguez et al., 2009; Nurieva et al.,
2008; Suto et al., 2008): T cell-depleted APCs were prepared by incubating
splenocytes from C57BL/6 mice with anti-Thy-1 (BD Bioscience) at 4C for
20 min, followed by rabbit complement (Cedarlane Laboratories) at 37C for
45 min and treatment with mitomycin-C (50 mg/ml, Sigma, 37C for 45 min),
followed by four washes. 2 3 105 naive sorted OT-II cells were cocultured
with 1 3 106 APCs in 1 ml/well of a 48-well plate, in the presence of 0.1
(Th0, Th2) or 1.0 (Th1, Th17, Tfh-like) mg/ml of OVA323-339 (AnaSpec) for
3–4 days in IMDM media (Invitrogen) under different skewing conditions: Th0:
aIFN-g (XMG1.2), aIL-12 (C17.8), aIL-4 (11B11, 10 mg/ml); Th1: aIL-4 plus
IL-12 (20 ng/ml); Th2: aIFN-g, aIL-12, plus IL-4 (40 ng/ml); Th17: aIFN-g,
aIL-4, aIL-12, plus TGF-b (5 ng/ml, R&D), IL-6 (20 ng/ml); and Tfh-like:
aIFN-g, aIL-4, aIL-12, aTGF-b (1D11, 20 mg/ml, antibodies from BioXCell),
IL-6 (100 ng/ml), IL-21 (50 ng/ml, cytokines fromPeprotech). After initial culture,
Th cells were either analyzed or further expanded in IL-2 (50 U/ml) for 3 days,
followed by a second round of differentiation for an additional 3 days.
Intracellular Cytokine Analysis and Flow Cytometry
Differentiated cells were restimulated with PMA (20 ng/ml) plus ionomycin
(1 mg/ml, Sigma) at 37C for 4–5 hr in the presence of GolgiStop (BD) for
the last 2.5 hr. Cells were fixed and permeabilized with Cytofix/CytopermSolu-
tion (BD Bioscience). All subsequent washes and antibody dilutions were
made with permeabilization buffer (eBioscience). Cells were incubated with
IL-21 R/Fc chimera (R&D Systems) for 1 hr, washed and stained with PE-
labeled affinity-purified F(ab’)2 goat anti-human Fcg antibody (Jackson Immu-
noResearch Laboratories) for 30min (modified fromSuto et al. [2008]), washed
twice, and stained with antibodies to IL-4 (11B11), IFN-g (XMG1.2), IL-17A
(17B7), and CD4 (RM4-5) (eBioscience) for 1 hr. CXCR5 staining used bio-
tinylated anti-CXCR5 (2G8, BD Bioscience) for 1 hr on ice, followed by APC
or PE-Cy7-labeled streptavidin (BD Bioscience). Secondary controls without
primary antibodies confirmed staining specificity. Additional information
provided in Supplemental Experimental Procedures.
Adoptive Transfer, Immunizations, and ELISAs
43 104 in vitro-differentiated GFP+OT-II T cells were retro-orbitally transferred
into Sh2d1a/ recipients 1 day prior to subcutaneous immunization in each
hind limb with 50 mg of NP13-OVA (Biosearch Technologies) emulsified in
Immunity
Function and Plasticity of Tfh-like CellsAlum (Pierce). Draining lymph nodes were analyzed on specified days postim-
munization. ELISAs were performed as described (Cannons et al., 2006).
ChIP-Seq
ChIP-Seq experiments were performed essentially as described previously
(Wei et al., 2009). In brief, T cells were treated with Micrococcal nuclease
(MNase) to generate mononucleosomes. Chromatin from naive and in vitro-
differentiated Th cells (1 3 107 cells) was immunoprecipitated with antibodies
against histone H3K4me3 (Abcam ab8580, Milipore 04-745) or H3K27me3
(Upstate 07-449, Milipore CS200603). For sorted Tfh cells, cells were immedi-
ately treated with MNase and native fragmented chromatin was stored
at 80C. Chromatin preparation from sorted samples (CXCR5+PD-1+ sorted
Tfh-like cells, a total of 33 106 cells [H3K4me3] and 73 106 cells [H3K27me3];
CXCR5hiPD-1hi ex vivo Tfh cells, 3 3 106 cells [H3K4me3], and 5 3 106 cells
[H3K27me3]) were pooled together and simultaneously processed as
described above. Immunoprecipitated DNA fragments were blunt-ended,
ligated to the Illumina adaptors, and sequenced with the Illumina GAII
sequencer.
Data Analyses by ChIP-Seq
Illumina-provided pipeline analysis was performed to obtain sequence reads
of 25 bp and uniquely matching reads were mapped to the mouse genome
(mm9) via the SICER peak calling program as described (Wei et al., 2009).
Only uniquely matching reads were retained. Data from Wei et al. [2009]
were also reanalyzed with the mm9 version of the mouse genome for compar-
ison and the output datawere converted to browser-extensible data (BED) files
in a window size of 200 bp as described previously (Wei et al., 2009), with or
without (for H3K27me3) peak calling. Results were uploaded for viewing and
comparative analyses in the UCSC genome browser.
Statistical Analyses
Statistical differences between analyzed groups were calculated with the
paired Student’s t test in Prism (Graph Pad) and Excel (Microsoft). Values of
p < 0.05 are considered significant.
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www.ncbi.nlm.nih.gov/geo) under accession numbers GSE32624 for gene
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